SG Americas Securities
KRRO icon

SG Americas Securities’s Korro Bio KRRO Stock Holding History

SG Americas Securities’s Portfolio KRRO Stock Details KRRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-203
Closed -$52K – 3227
2021
Q4 		$52K Sell
203
-234
-54% -$71.1K ﹤0.01% 3183
2021
Q3 		$154K Buy
+437
New +$172K ﹤0.01% 3411
2020
Q3 		– Sell
-306
Closed -$355K – 3092
2020
Q2 		$355K Buy
+306
New +$276K ﹤0.01% 2392

Other funds holding KRRO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

SG Americas Securities's KRRO Position: Q1 2022 in Review

SG Americas Securities sold out of Korro Bio (KRRO) in Q1 2022, closing a stake of 203 shares — an estimated $52K sold.

SG Americas Securities first reported a position in KRRO in Q2 2020 and held it in 3 quarters. The position peaked at $355K in Q2 2020. 85 funds tracked by Wall St. Rank hold KRRO as of Q1 2022.

  • SG Americas Securities reported no remaining Korro Bio position as of Q1 2022 after selling out during the quarter.
  • SG Americas Securities sold 203 Korro Bio shares in Q1 2022, an estimated $52K.
  • SG Americas Securities first reported a position in Korro Bio in Q2 2020 and held it in 3 quarters.
  • SG Americas Securities's Korro Bio position peaked at $355K in Q2 2020.
  • 85 funds tracked by Wall St. Rank held Korro Bio as of Q1 2022.

Based on SG Americas Securities's 13F filing for Q1 2022, filed 29 Apr 2022.